CD274 and neoplasm: Programmed death 1 (PD-1) is expressed on activated T cells and negatively regulate T-cell responses, acting as a key checkpoint molecule in tumor-induced immune suppression; blockade of the interaction of PD-1 with its ligand, PD-L1 or PD-L2, has been shown to enhance the antitumor activity of T cells (1–4).